Coronavirus puts drug repurposing on the fast track - PubMed (original) (raw)

Coronavirus puts drug repurposing on the fast track

Charlotte Harrison. Nat Biotechnol. 2020 Apr.

No abstract available

PubMed Disclaimer

Similar articles

• The Biology of Pulmonary Coronavirus Infection Underscores Host-Directed Therapies as an Option.
  Brown RE, Hunter RL. Brown RE, et al. Ann Clin Lab Sci. 2020 Mar;50(2):287-288. Ann Clin Lab Sci. 2020. PMID: 32366572 No abstract available.
• Repurposing host-based therapeutics to control coronavirus and influenza virus.
  Li CC, Wang XJ, Wang HR. Li CC, et al. Drug Discov Today. 2019 Mar;24(3):726-736. doi: 10.1016/j.drudis.2019.01.018. Epub 2019 Jan 31. Drug Discov Today. 2019. PMID: 30711575 Free PMC article. Review.
• The past, present and future of RNA respiratory viruses: influenza and coronaviruses.
  Makarov V, Riabova O, Ekins S, Pluzhnikov N, Chepur S. Makarov V, et al. Pathog Dis. 2020 Oct 7;78(7):ftaa046. doi: 10.1093/femspd/ftaa046. Pathog Dis. 2020. PMID: 32860686 Free PMC article. Review.
• The value of targeting recombination as a strategy against coronavirus diseases.
  Santiago E, Caballero A. Santiago E, et al. Heredity (Edinb). 2020 Oct;125(4):169-172. doi: 10.1038/s41437-020-0337-5. Epub 2020 Jun 30. Heredity (Edinb). 2020. PMID: 32606420 Free PMC article. No abstract available.
• Natural Antioxidants: A Review of Studies on Human and Animal Coronavirus.
  Diniz LRL, Bezerra Filho CDSM, Fielding BC, de Sousa DP. Diniz LRL, et al. Oxid Med Cell Longev. 2020 Aug 12;2020:3173281. doi: 10.1155/2020/3173281. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32855764 Free PMC article. Review.

Cited by

• A computational approach to aid clinicians in selecting anti-viral drugs for COVID-19 trials.
  Mongia A, Saha SK, Chouzenoux E, Majumdar A. Mongia A, et al. Sci Rep. 2021 Apr 27;11(1):9047. doi: 10.1038/s41598-021-88153-3. Sci Rep. 2021. PMID: 33907209 Free PMC article.
• Therapeutic Strategies Against COVID-19 and Structural Characterization of SARS-CoV-2: A Review.
  Jeong GU, Song H, Yoon GY, Kim D, Kwon YC. Jeong GU, et al. Front Microbiol. 2020 Jul 14;11:1723. doi: 10.3389/fmicb.2020.01723. eCollection 2020. Front Microbiol. 2020. PMID: 32765482 Free PMC article. Review.
• An update on emerging therapeutics to combat COVID-19.
  Shah NN, Nabi SU, Rather MA, Kalwar Q, Ali SI, Sheikh WM, Ganai A, Bashir SM. Shah NN, et al. Basic Clin Pharmacol Toxicol. 2021 Aug;129(2):104-129. doi: 10.1111/bcpt.13600. Epub 2021 Jun 11. Basic Clin Pharmacol Toxicol. 2021. PMID: 33977663 Free PMC article. Review.
• Repositioning Chromones for Early Anti-inflammatory Treatment of COVID-19.
  Sestili P, Stocchi V. Sestili P, et al. Front Pharmacol. 2020 Jun 5;11:854. doi: 10.3389/fphar.2020.00854. eCollection 2020. Front Pharmacol. 2020. PMID: 32581809 Free PMC article.
• Implementing Personalized Medicine in COVID-19 in Andalusia: An Opportunity to Transform the Healthcare System.
  Dopazo J, Maya-Miles D, García F, Lorusso N, Calleja MÁ, Pareja MJ, López-Miranda J, Rodríguez-Baño J, Padillo J, Túnez I, Romero-Gómez M. Dopazo J, et al. J Pers Med. 2021 May 26;11(6):475. doi: 10.3390/jpm11060475. J Pers Med. 2021. PMID: 34073493 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database